News

Mr Kochersperger has over two decades of product development and commercialization experience at life sciences tools companies. He will lead the team focusing on the commercial design and

NovaBay has recently filed additional patent applications including ones for compositions of matter of additional Aganocide compounds, methods of use and formulations, and is preparing further applications in

Based on the expected full year revenue range, fourth quarter 2008 revenue grew 76% to 87% year-over-year despite a challenging global operating environment that included volatile foreign exchange

Sinclair received an immediate payment of $3.1 million in cash in place of future royalties that it would have received under the existing agreement. This payment is equivalent

The advisors also recommended that the drug be available under a risk evaluation and mitigation strategy. If approved, Sabril would be the first and only drug approved in

Kolltan has also appointed Michael Schmertzler as its new CEO and director, and Yaron Hadari as vice president of research. Joseph Schlessinger, co-founder, chief scientist and a director

The milestone payment is triggered by the recent FDA approval of Prism’s new drug application (NDA) for Nexterone (amiodarone HCl) injection, a patent-protected, cosolvent free formulation of the

Mr Buehler is currently senior vice president of global markets and chief marketing officer of Alcon Laboratories, a subsidiary of Alcon. In this capacity, he is responsible for

Midwest Dental is a dental management company headquartered in Mondovi, Wisconsin. Under the terms of this multi-year agreement, OralDNA will provide diagnostic laboratory testing to Midwest Dental to